Unternehmen
DEMCON LIFE SCIENCES & HEALTH ENSCHEDE BV
DEMCON LIFE SCIENCES & HEALTH ENSCHEDE BV – Unternehmen mit Aktivitäten in Forschung und Innovation.
Weiter entdecken
Ähnliche Beiträge
Projekt
→
Presidency Conference on the Future of Life Sciences
On the first of January 2023, Sweden took over the Presidency of the Council of the European Union. One prioritised area for Swed… Beitrag ansehen →
Projekt
→
Accelerating datafication for support of EU health priorities, greening of biobanks and integrated approach to “One Health”
Since its creation, the Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consorti… Beitrag ansehen →
Projekt
→
Alliance4Life Bridging the Research and Innovation Gap in Life Sciences
The persisting R&I gap between Western and Eastern Europe is a major challenge to the EU. It includes under-developed R&I ecosyst… Beitrag ansehen →
Projekt
→
An Integrated Life-Course Approach for Person-Centred Solutions and Care for Ageing with Multi-morbidity in the European Regions - STAGE; Stay Healthy Through Ageing
STAGE aims to demonstrate the importance and feasibility of a life-course approach to prevent accelerated ageing, as defined by t… Beitrag ansehen →
Projekt
→
Hpc AlliaNce for Applications and supercoMputing Innovation: the Europe - Japan collaboration
A number of European leading Research Organizations (referred as RTOs hereafter) and research supporting organizations, with a lo… Beitrag ansehen →
Projekt
→
Abortion, Law and Nature
"The ALaN project brings together philosophy, gender studies and life sciences to question the impact of representations of natur… Beitrag ansehen →
Passend zu diesem Beitrag
Forschungsprojekte
- Scalable and Modular robotic tools for pipeline inspection and repair The European water network distribution is plagued by leaks that cause a staggering 20% of drinking water to… →
- LIGHT BASED MULTISENSING DEVICE FOR SCREENING OF PATHOGENS AND NUTRIENTS IN BIOREACTORS The bioreactor industry is currently flourishing with a global market valued estimated at 2.3 B€ in 2020 and… →
- Dypha: adding the dimension of time to cell culture The current preclinical drug development pipeline is highly inefficient with 9 out of 10 drugs failing when f… →